ADC 2019: Australian reports shed light on SGLT2-related DKA

Diabetic ketoacidosis risk in patients taking SGLT2 inhibitors goes beyond the perioperative period and is more often associated with acute illness and infection, according to case reports presented at the Australasian Diabetes Congress in Sydney. A review of 21 cases of SGLT2 inhibitor-associated DKA at Blacktown Hospital, NSW, found that most cases were precipitated by ...

Already a member?

Login to keep reading.

© 2021 the limbic